New 3D method could help doctors better track cancer treatment effectiveness
NCT ID NCT07319767
Summary
This study looked at whether a new 3D measurement method (TDTP-RECIST) works better than the current standard (RECIST 1.1) for tracking how irregularly shaped tumors respond to pre-surgery treatment. Researchers reviewed past medical scans and records of 120 adults with breast, pancreatic, or biliary cancers who received treatment before surgery. They compared how well different measurement methods predicted what was actually found in the tumor tissue after removal, aiming to help doctors choose the best tool for future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhongshan Hospital, Fudan University
Shanghai, China
Conditions
Explore the condition pages connected to this study.